Elevance Health Faces Sanctions from Medicare Regulator

Investors encouraged to contact law firm about potential securities law violations

Apr. 16, 2026 at 12:20am

Got story updates? Submit your updates here. ›

A minimalist studio still life photograph featuring a stack of medical insurance documents, a calculator, and a gavel resting on a clean, monochromatic background, conceptually representing the abstract corporate strategy, finance, and legal risks facing Elevance Health.The proposed CMS sanctions against Elevance Health expose the complex regulatory landscape and legal risks facing major healthcare insurers.NYC Today

Elevance Health, Inc. has disclosed that the Centers for Medicare & Medicaid Services (CMS) intends to impose intermediate sanctions on the company, suspending enrollment of Medicare beneficiaries into its Medicare Advantage-Prescription Drug (MA-PD) plans and certain communication activities. CMS cited alleged noncompliance by Elevance with certain Medicare Advantage risk adjustment data submission requirements for dates of service prior to April 3, 2023.

Why it matters

The proposed sanctions from CMS could have significant financial and operational impacts on Elevance Health, one of the largest health insurance providers in the United States. Investors are being encouraged to contact a law firm about potential securities law violations related to the company's disclosures and the market's reaction to the news.

The details

Elevance Health said the sanctions are scheduled to take effect on March 31, 2026 unless CMS determines the issues have been satisfactorily addressed. The company's stock price declined by $25.93 per share, or approximately 8.1%, following the disclosure.

  • On March 2, 2026, Elevance disclosed the CMS sanctions in a filing with the U.S. Securities and Exchange Commission.
  • The sanctions are scheduled to take effect on March 31, 2026 unless CMS determines the issues have been satisfactorily addressed.

The players

Elevance Health, Inc.

A large health insurance provider in the United States.

Centers for Medicare & Medicaid Services (CMS)

The federal agency that administers the Medicare program.

Kirby McInerney LLP

A New York-based plaintiffs' law firm investigating potential securities law violations by Elevance Health.

Got photos? Submit your photos here. ›

What they’re saying

“The law firm of Kirby McInerney LLP reminds investors its investigation on behalf of Elevance Health, Inc. ('Elevance' or the 'Company') (NYSE: ELV) investors concerning the Company's and/or members of its senior management's possible violation of the federal securities laws or other unlawful business practices.”

— Lauren Molinaro, Attorney, Kirby McInerney LLP

What’s next

The judge in the case will decide on Tuesday whether or not to allow Elevance Health to continue operating its Medicare Advantage plans during the sanctions period.

The takeaway

This case highlights the importance of regulatory compliance for large healthcare companies like Elevance Health, and the potential financial and reputational risks they face if they fail to meet government requirements. Investors will be closely watching how Elevance responds to the CMS sanctions and whether any securities law violations are uncovered.